626-Advancing Cellular Immunotherapies for Solid Tumors

Paper Talk · Mar 12, 2026 · 15m

This review article examines the evolution and current state of cellular immunotherapies specifically designed to treat solid tumors. While these therapies have achieved significant success in blood cancers, the authors identify major functional hurdles such as poor tumor penetration, target recognition errors, and the immunosuppressive nature of the tumor environment. The text outlines various therapeutic modalities, including engineered T cells, NK cells, and cellular vaccines, while detailing how synthetic biology and genetic engineering can enhance their efficacy. Beyond biological…